SRC and cancer: The Src/ERK pathway is associated with glucose metabolism and the metabolic plasticity of cancer cells [342], while GSK-3/β-catenin signalling is involved in a number of diverse pathways [343]; their suppression leads to stoppage of cells in the G0/G1 phase, as shown by Park et al. on human colorectal HCT 116 cancer cells [340].